Report
EUR 232.00 For Business Accounts Only

Diplomat Pharmacy, Inc.: Update to credit analysis - niche specialty drug distributor & PBM, competing in rapidly changing industry

Our credit view of Diplomat reflecting its small market share in the dynamic pharmaceutical supply chain industry, mitigated by solid cash flow and a debt/EBITDA target of <3.0x.
Underlying
Diplomat Pharmacy Inc.

Diplomat Pharmacy is a provider of specialty pharmacy services. The company's programs consist of the following business services: Dispensing of Specialty Pharmacy and Infusion Drugs, which is engages in the dispensing of drugs and the reporting of data associated with those dispenses to pharmaceutical manufacturers and other outside companies; Hospital and Health System Services, which provides clinical and administrative support services to hospitals and health systems that dispense medications through their outpatient pharmacies; and Hub Services, which are centralized management services for collaboration and efficiency among the main stakeholders in the access of care to medications.

Provider
Moody's Investors Service
Moody's Investors Service

Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:

  • 130 countries
    11,000 corporate issuers
    21,000 public finance issuers
    76,000 structured finance obligations



Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.



Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions. 

Other Reports on these Companies
Other Reports from Moody's Investors Service

ResearchPool Subscriptions

Get the most out of your insights

Get in touch